(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

BETA-HIDROXIETILAMINAS SUBSTITUÍDAS POR HETEROARILA PARA USO NO TRATAMENTO DE HIPERGLICEMIA

Em ExigênciaInvention PatentPCT · GB2018052595

Application data

Number

112020005113

Type

Invention Patent

Filing

09/13/2018

Publication

09/15/2020

PCT

GB2018052595

Progress at the INPI

Office action pending
  1. Filing09/13/18
  2. Publication09/15/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).

Deadline to answer the office action:08/31/2026(6 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/02/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ATROGI AB

SE

See this company's full portfolio

Inventors

B. P. (pessoa física)

SE

T. B. (pessoa física)

SE

Technical data

Priority claims

GB

1714745.5 · 09/13/2017

Abstract

A presente invenção se refere a um composto de Fórmula I ou um sal farmaceuticamente aceitável do mesmo, em que o anelquecontémQ1 aQ5,eosgruposR1,R2 eR3,têmos significados conforme fornecidos na descrição.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Exigência - art. 36 da LPI

#6.1

06/02/2026

RPI 2891

Parecer de pré-exame

#6.23

07/19/2022

RPI 2689

Adição na publicação

#15.35

11/23/2021

RPI 2655

Notificação de entrada na fase nacional - PCT

#1.3

09/15/2020

RPI 2593

Alteração de dados cadastrais

#1.1

03/24/2020

RPI 2568

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.